FDA approves selegiline transdermal for the treatment of major depressive disorder in adults

被引：0

|

作者：

Naccari, C

机构：

来源：

CNS SPECTRUMS | 2006年 / 11卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：253 / 253

页数：1

相关论文

共 50 条

[21] Transdermal Scopolamine for Treatment-Resistant Major Depressive Disorder
Liester, Mitchell B.
Shash, Delia S.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
[22] Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by J. Alexander Bodkin
J. Alexander Bodkin
Drugs, 2007, 67 (2) : 266 - 266
[23] Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by Thomas C. Baghai
Thomas C. Baghai
Drugs, 2007, 67 (2) : 266 - 267
[24] Escitalopram for treatment of major depressive disorder in adults
Llorca, PM
Brousse, G
Schwan, R
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (04): : 490 - 501
[25] FDA approves new treatment for adults with migraine
不详
NURSE PRACTITIONER, 2020, 45 (05): : 56 - 56
[26] Efficacy of selegiline transdermal system for major depressive disorder as measured by the HAM-D 6-item Bech subscale
Robinson, D. S.
Azzar, A. J.
Moonsammy, G. I.
Campbell, B.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S260 - S261
[27] Efficacy of selegiline transdermal system for major depressive disorder as measured by the HAM-D 6-item Bech subscale
Sambunaris, Angelo
Campbell, Bryan
Azzaro, Albert
Moonsammy, George
Robinson, Donald
NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S94 - S94
[28] Medicine and Nonmedicine Options for the Treatment of Adults With Major Depressive Disorder
不详
ANNALS OF INTERNAL MEDICINE, 2016, 164 (05) : I18 - I18
[29] Psychosocial Treatment Options for Major Depressive Disorder in Older Adults
Renn B.N.
Areán P.A.
Current Treatment Options in Psychiatry, 2017, 4 (1) : 1 - 12
[30] PREDICTION OF TREATMENT RESPONSE TO EXERCISE IN ADULTS WITH MAJOR DEPRESSIVE DISORDER
Brush, Christopher J.
Ehmann, Peter J.
Alderman, Brandon L.
ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S769 - S769

← 1 2 3 4 5 →